The contribution of HLA genes to IBD susceptibility and phenotype

Best Practice and Research: Clinical Gastroenterology

Volumn 18, Issue 3, 2004, Pages 577-596

  Yap, Lee Min ^a   Ahmad, Tariq ^a   Jewell, Derek P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bowel diseases; Crohn's disease; GENET; Human leukocyte antigens; Inflammatory; MESH; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; HEAT SHOCK PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

CHROMOSOME 6P; CLINICAL FEATURE; CROHN DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; ETHNIC DIFFERENCE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; LYMPHOCYTE FUNCTION; MARKER GENE; METHODOLOGY; PHENOTYPE; POPULATION RESEARCH; PREDICTION; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HEAT-SHOCK PROTEINS; HLA ANTIGENS; HUMANS; LINKAGE (GENETICS); LYMPHOTOXIN-ALPHA; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442710485     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2004.01.003     Document Type: Review

References (110)

1. Dausset J. Nenna A. Presence of leuko-agglutinin in the serum of a case of chronic agranulocytosis Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 146 19-20 1952 1539-1541
2. Dausset J. Iso-leuko-antibodies Acta Haematologica 20 1-4 1958 156-166
3. Payne R. Rolfs M.R. Fetomaternal leukocyte incompatibility The Journal of Clinical Investigation 37 12 1958 1756-1763
4. van Rood J.J. Eernisse J.G. van Leeuwen A. Leukocyte antibodies in sera of pregnant women Nature 181 1958 1735-1736
5. The MHC Sequencing Consortium Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 1999; 401(6756): 921-923.
6. Hughes A.L. Natural selection and the diversification of vertebrate immune effectors Immunological Reviews 190 2002 161-168
7. Coppin H.L. Carmichael P. Lombardi G. et al. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition European Journal of Immunology 23 2 1993 343-349
8. Ahmad T. Neville M. Marshall S.E. et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC Human Molecular Genetics 12 6 2003 647-656
9. Schwartz S.E. Siegelbaum S.P. Fazio T.L. et al. Regional enteritis: evidence for genetic transmission by HLA typing Annals of Internal Medicine 93 3 1980 424-427
10. Achord J.L. Gunn C.H. Jr. Jackson J.F. Regional enteritis and HLA concordance in multiple siblings Digestive Diseases and Sciences 27 4 1982 330-332
11. Eade O.E. Moulton C. MacPherson B.R. et al. haplotype segregation in familial Crohn's disease Gastroenterology 79 2 1980 271-275
12. Pena A.S. Biemond I. Kuiper G. et al. HLA antigen distribution and HLA haplotype segregation in Crohn's disease Tissue Antigens 16 1 1980 56-61
13. Colombel J.F. Guillemot F. Van Gossum A. et al. Familial Crohn's disease in multiple siblings: no linkage to the HLA system Gastroenterologie Clinique et Biologique 13 8-9 1989 676-678
14. Hugot J.P. Laurent-Puig P. Gower-Rousseau C. et al. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D American Journal of Medical Genetics 52 2 1994 207-213
15. Hugot J.P. Laurent-Puig P. Gower-Rousseau C. et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 Nature 379 6568 1996 821-823
16. Parkes M. Satsangi J. Lathrop G.M. et al. Susceptibility loci in inflammatory bowel disease Lancet 348 9041 1996 1588
17. Ma Y. Ohmen J.D. Li Z. et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease Inflammatory Bowel Diseases 5 4 1999 271-278
18. Satsangi J. Welsh K.I. Bunce M. et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease Lancet 347 9010 1996 1212-1217
19. Weissenbach J. Gyapay G. Dib C. et al. A second-generation linkage map of the human genome Nature 359 6398 1992 794-801
20. Hampe J. Schreiber S. Shaw S.H. et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort American Journal of Human Genetics 64 3 1999 808-816
21. Rioux J.D. Silverberg M.S. Daly M.J. et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci American Journal of Human Genetics 66 6 2000 1863-1870
22. Dechairo B. Dimon C. van Heel D. et al. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3) European Journal of Human Genetics 9 8 2001 627-633
23. Selby W.S. Janossy G. Mason D.Y. Jewell D.P. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease Clinical and Experimental Immunology 53 3 1983 614-618
24. Powrie F. Leach M.W. Mauze S. et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice International Immunology 5 11 1993 1461-1471
25. Stokkers P.C. Reitsma P.H. Tytgat G.N. van Deventer S.J. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis Gut 45 3 1999 395-401
26. Futami S. Aoyama N. Honsako Y. et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression Digestive Diseases and Sciences 40 4 1995 814-818
27. Yoshitake S. Kimura A. Okada M. et al. HLA class II alleles in Japanese patients with inflammatory bowel disease Tissue Antigens 53 4 Pt 1 1999 350-358
28. Trachtenberg E.A. Yang H. Hayes E. et al. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations Human Immunology 61 3 2000 326-333
29. Ahmad T. Armuzzi A. Neville M. et al. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis Tissue Antigens 62 6 2003 527-535
30. Roussomoustakaki M. Satsangi J. Welsh K. et al. Genetic markers may predict disease behavior in patients with ulcerative colitis Gastroenterology 112 6 1997 1845-1853
31. Bouma G. Oudkerk Pool M. Crusius J.B. et al. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD) Clinical and Experimental Immunology 109 1 1997 175-179
32. Gulwani-Akolkar B. Akolkar P.N. Lin X.Y. et al. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population Inflammatory Bowel Diseases 6 2 2000 71-76
33. Bahram S. Mizuki N. Inoko H. Spies T. Nucleotide sequence of the human MHC class I MICA gene Immunogenetics 44 1 1996 80-81
34. Groh V. Bahram S. Bauer S. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proceedings of the National Academy of Sciences of the USA 93 22 1996 12445-12450
35. Bahram S. Bresnahan M. Geraghty D.E. Spies T. A second lineage of mammalian major histocompatibility complex class I genes Proceedings of the National Academy of Sciences of the USA 91 14 1994 6259-6263
36. Jinushi M. Takehara T. Kanto T. et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection Journal of Immunology 170 3 2003 1249-1256
37. Diefenbach A. Jamieson A.M. Liu S.D. et al. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages Nature Immunology 1 2 2000 119-126
38. Bauer S. Groh V. Wu J. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 5428 1999 727-729
39. Groh V. Steinle A. Bauer S. Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells Science 279 5357 1998 1737-1740
40. Groh V. Rhinehart R. Randolph-Habecker J. et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells Nature Immunology 2 3 2001 255-260
41. Das H. Groh V. Kuijl C. et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function Immunity 15 1 2001 83-93
42. Tieng V. Le Bouguenec C. du Merle L. et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA Proceedings of the National Academy of Sciences of the USA 99 5 2002 2977-2982
43. Berstad A.E. Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract Gut 42 4 1998 522-529
44. Holmes M.A. Li P. Petersdorf E.W. Strong R.K. Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D Journal of Immunology 169 3 2002 1395-1400
45. Yao Z.V.A. Helmberg W. Keller E. Definition of new alleles of MIC-A using sequencing-based typing European Journal of Immunogenetics 26 1999 225-232
46. Steinle A. Li P. Morris D.L. et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family Immunogenetics 53 4 2001 279-287
47. Seki S.S. Sugimura K. Ota M. et al. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese Tissue Antigens 58 2 2001 71-76
48. Glas J. Martin K. Brunnler G. et al. MICA, MICB and C11 polymorphism in Crohn's disease and ulcerative colitis Tissue Antigens 58 4 2001 243-249
49. Orchard T.R. Dhar A. Simmons J.D. et al. MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy Clinical and Experimental Immunology 126 3 2001 437-440
50. Ahmad T. Marshall S.E. Mulcahy-Hawes K. et al. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility Tissue Antigens 60 2 2002 164-179
51. Noguchi M. Hiwatashi N. Liu Z. Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease Gut 43 2 1998 203-209
52. Braegger C.P. Nicholls S. Murch S.H. et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation Lancet 339 8785 1992 89-91
53. Komatsu M. Kobayashi D. Saito K. et al. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR Clinical Chemistry 47 7 2001 1297-1301
54. Akazawa A. Sakaida I. Higaki S. et al. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase Journal of Gastroenterology 37 5 2002 345-353
55. Kontoyiannis D. Pasparakis M. Pizarro T.T. et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies Immunity 10 3 1999 387-398
56. Neurath M.F. Fuss I. Pasparakis M. et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice European Journal of Immunology 27 7 1997 1743-1750
57. Present D.H. Rutgeerts P. Targan S. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease The New England Journal of Medicine 340 18 1999 1398-1405
58. Targan S.R. Hanauer S.B. van Deventer S.J. et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group The New England Journal of Medicine 337 15 1997 1029-1035
59. Negoro K. Kinouchi Y. Hiwatashi N. et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene Gastroenterology 117 5 1999 1062-1068
60. Mascheretti S. Hampe J. Kuhbacher T. et al. Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab The Pharmacogenomics Journal 2 2 2002 127-136
61. Louis E. Peeters M. Franchimont D. et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clinical and Experimental Immunology 119 1 2000 64-68
62. van Heel D.A. Udalova I.A. De Silva A.P. et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors Human Molecular Genetics 11 11 2002 1281-1289
63. O'Callaghan N.J. Adams K.E. van Heel D.A. Cavanaugh J.A. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population Scandinavian Journal of Gastroenterology 38 5 2003 533-534
64. Yoshida H. Naito A. Inoue J. et al. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches Immunity 17 6 2002 823-833
65. Bouma G. Crusius J.B. Oudkerk Pool M. et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease Scandinavian Journal of Immunology 43 4 1996 456-463
66. Koss K. Satsangi J. Fanning G.C. et al. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies Genes and Immunity 1 3 2000 185-190
67. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity Nature Reviews. Immunology 2 3 2002 185-194
68. Esaki M. Furuse M. Matsumoto T. et al. Polymorphism of heat-shock protein gene HSP70-2 in Crohn disease: possible genetic marker for two forms of Crohn disease Scandinavian Journal of Gastroenterology 34 7 1999 703-707
69. Ahmad T. Armuzzi A. Bunce M. et al. The molecular classification of the clinical manifestations of Crohn's disease Gastroenterology 122 4 2002 854-866
70. Freely associating. Nature Genetics 1999; 22(1): 1-2.
71. Gambaro G. Anglani F. D'Angelo A. Association studies of genetic polymorphisms and complex disease Lancet 355 9200 2000 308-311
72. Abecasis G.R. Cardon L.R. Cookson W.O. et al. Association analysis in a variance components framework Genetic Epidemiology 21 supplement 1 2001 S341-S346
73. Tabor H.K. Risch N.J. Myers R.M. Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations Nature Reviews. Genetics 3 5 2002 391-397
74. Colhoun H.M. McKeigue P.M. Davey Smith G. Problems of reporting genetic associations with complex outcomes Lancet 361 9360 2003 865-872
75. van den Berg-Loonen E.M. Dekker-Saeys B.J. Meuwissen S.G. et al. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases Journal of Immunogenetics 4 3 1977 167-175
76. Tsuchiya M. Yoshida T. Asakura H. et al. HLA antigens and ulcerative colitis in Japan Digestion 15 4 1977 286-294
77. Woodrow J.C. Lewkonia R.M. McConnell R.B. et al. HLA antigens in inflammatory bowel disease Tissue Antigens 11 2 1978 147-152
78. Delpre G. Kadish U. Gazit E. et al. HLA antigens in ulcerative colitis and Crohn's disease in Israel Gastroenterology 78 6 1980 1452-1457
79. Sugimura K. Asakura H. Mizuki N. et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis Human Immunology 36 2 1993 112-118
80. Sashio H. Tamura K. Ito R. et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively Immunogenetics 53 12 2002 1020-1027
81. Bayless T.M. Tokayer A.Z. Polito J.M. 2nd et al. Crohn's disease: concordance for site and clinical type in affected family members-potential hereditary influences Gastroenterology 111 3 1996 573-579
82. Colombel J.F. Grandbastien B. Gower-Rousseau C. et al. Clinical characteristics of Crohn's disease in 72 families Gastroenterology 111 3 1996 604-607
83. Peeters M. Nevens H. Baert F. et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics Gastroenterology 111 3 1996 597-603
84. Annese V. Andreoli A. Astegiano M. et al. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian study group for the disease of colon and rectum The American Journal of Gastroenterology 96 10 2001 2939-2945
85. Bouma G. Crusius J.B. Garcia-Gonzalez M.A. et al. Genetic markers in clinically well defined patients with ulcerative colitis (UC) Clinical and Experimental Immunology 115 2 1999 294-300
86. Yamamoto-Furusho J.K. Uscanga L.F. Vargas-Alarcon G. et al. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis Human Immunology 64 1 2003 119-123
87. Silverberg M.S. Mirea L. Bull S.B. et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease Inflammatory Bowel Diseases 9 1 2003 1-9
88. Louis E. Belaiche J. Genetics of Crohn's disease behaviour Acta Gastro-enterologica Belgica 63 4 2000 377-379
89. Reinshagen M. Loeliger C. Kuehnl P. et al. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany Gut 38 4 1996 538-542
90. Danze P.M. Colombel J.F. Jacquot S. et al. Association of HLA class II genes with susceptibility to Crohn's disease Gut 39 1 1996 69-72
91. Fernandez A. et al. Inflammatory Bowel Disease, in press, 2004.
92. Orchard T.R. Wordsworth B.P. Jewell D.P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history Gut 42 3 1998 387-391
93. Orchard T.R. Satsangi J. Van Heel D. Jewell D.P. Genetics of inflammatory bowel disease: a reappraisal Scandinavian Journal of Immunology 51 1 2000 10-17
94. Sachar D.B. Andrews H.A. Farmer R.G. et al. Proposed classification of patient subgroups in Crohn's disease Gastroenterology International 5 1992 141-154
95. Gasche C. Scholmerich J. Brynskov J. et al. A simple classification of Crohn's disease: report of the working party for the world congresses of gastroenterology, Vienna 1998 Inflammatory Bowel Diseases 6 1 2000 8-15
96. Steinhart A.H. Girgrah N. McLeod R.S. Reliability of a Crohn's disease clinical classification scheme based on disease behavior Inflammatory Bowel Diseases 4 3 1998 228-234
97. Cosnes J. Cattan S. Blain A. et al. Long-term evolution of disease behavior of Crohn's disease Inflammatory Bowel Diseases 8 4 2002 244-250
98. Louis E. Collard A. Oger A.F. et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease Gut 49 6 2001 777-782
99. Powell-Tuck J. Ritchie J.K. Lennard-Jones J.E. The prognosis of idiopathic proctitis Scandinavian Journal of Gastroenterology 12 6 1977 727-732
100. Moum B. Ekbom A. Vatn M.H. Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time The American Journal of Gastroenterology 94 6 1999 1564-1569
101. Forcione D.G. Sands B. Isselbacher K.J. et al. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele Proceedings of the National Academy of Sciences of the USA 93 10 1996 5094-5098
102. Cariappa A. Sands B. Forcione D. et al. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease Gut 43 2 1998 210-215
103. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for suspectibility loci on chromosomes 3, 7, 12. Nature Genetics 1996; 14(2): 199-202.
104. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM et al. Identification of novel suspectbility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and 1BD1. Proceedings of National Academy of Sciences of the United States of America 1998; 95(13): 7502-7507.
105. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al. Linkage of inflammatory bowel disease to human chromosome 69. American Joural of Human Genetics 1999; 65(6): 1647-1655.
106. Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, et al. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parameteric analyses. Gut 1999; 44(4): 519-526.
107. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE. High-density genome scan in Crohn disease show confirmed linkage to chromosome 14q11-12. American Journal of Human Genetics 2000; 66(6): 1857-1862.
108. Vermeire S. Study on genetic polymorphisms and serological markers in inflammatory bowel disease. Faculty of Medicine. Leuven 2001; 121.
109. Williams CN, Kocher K, Lander ES, Daly MJ, Rioux JD. Using a genomewide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD loci. Inflammatory Bowl Disease. 2002; 8(6): 375-381.
110. Annese V, Latiano A, Bovio P, Forabosco P, Piepoli A, Lombardi G, et al. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - a GISC study. European Journal of Human Genetics 1999; 7(5): 567-573.